News

September 29, 2020September 29, 2020

STRO-002 Trial Update Supports Its Safety, Activity in Advanced Cancer

News

Updated interim data from a Phase 1 clinical trial continues to support the safety and anti-tumor activity of Sutro Biopharma’s STRO-002 for heavily pre-treated women with advanced ovarian cancer. About one-quarter of patients receiving ... Read more

September 24, 2020September 24, 2020

Lynparza Combo Recommended by EU Committee as First-line Maintenance for Advanced Ovarian Cancer

News

Lynparza (olaparib), in combination with bevacizumab, has been recommended for approval in the European Union (EU) as a first-line maintenance therapy for women with advanced ovarian cancer positive for homologous recombination deficiency (HRD) and who ... Read more

September 22, 2020September 22, 2020

CHMP Favors Zejula as First-line Maintenance Therapy for Platinum-sensitive Advanced Ovarian Cancer

News

The Committee for Medicinal Products for Human Use (CHMP) has recommended Zejula (niraparib) as a first-line maintenance therapy for women with advanced ovarian cancer who responded to platinum-based chemotherapy. This favorable opinion ... Read more

September 17, 2020September 17, 2020

Checkpoint Inhibitor CTX-2026 Shows Promising Efficacy in Preclinical Study

News

Compass Therapeutics‘ CTX-2026, an antibody targeting the protein BTN3A1, could be therapeutic in ovarian cancer by helping the immune system destroy cancer cells, preclinical data show. The study, “BTN3A1 governs ... Read more

September 15, 2020September 15, 2020

Newk’s Cares Honors Late Co-founder Lori Newcomb During Awareness Month

News

Newk’s Cares is honoring the legacy of co-founder Lori Newcomb this September during Ovarian Cancer Awareness Month with fundraising initiatives online and at the more than 100 Newk’s Eatery restaurants. ... Read more

September 10, 2020September 10, 2020

Pap Smear Samples May Aid Early Diagnosis of Common Ovarian Cancer

News

Genetic material collected in routine cervical cancer screenings could be used to screen for ovarian cancer several years before disease symptoms are evident, possible speeding diagnosis and treatment, a study suggests. ... Read more

September 8, 2020September 8, 2020

National Ovarian Cancer Coalition Readies ‘Together in Teal’ Virtual Fundraiser

News

The National Ovarian Cancer Coalition (NOCC) is hosting its annual Together in Teal — No Boundaries fundraiser as a nationwide virtual celebration on Sept. 26, it announced in a press release. ... Read more

September 3, 2020September 3, 2020

Research Alliance Hopes to Raise $200K During Awareness Month

News

The Ovarian Cancer Research Alliance (OCRA) is hoping to raise $200,000 in this year’s awareness month campaign to help fund research and support those with the disease, the organization announced. ... Read more

September 1, 2020September 1, 2020

Organ-on-a-chip Device Shows How Cancer Cells Interact With Platelets to Drive Metastasis

News

To communicate with platelets and start the process of cancer spread, ovarian cancer cells are able to break the barriers of blood vessels and let platelets inside the tumor environment, ... Read more

August 27, 2020August 27, 2020

First Ovarian Cancer Patients Dosed in Phase 2 of OVATION 2 Trial

News

The first two patients have been randomized in Phase 2 of the OVATION 2 trial testing the immunotherapy candidate GEN-1 in newly diagnosed advanced ovarian cancer. Celsion Corporation, the immunotherapy’s developer, expects ... Read more